How I got rid of my gyno
Going to make this short and sweet.
Lots of guys on here wondering what the best protocol is for reducing, or getting rid of existing gyno. I've tried lots of things, and I'm going to outline a plan that is relatively safe, side effect free that got rid of my gyno, that I had for many years from puberty and PH.
I had REAL gyno. Lumps, tissue, pain, ugliness, puffiness. It was a mess.
The plan
I have seen extremely good results with low dosed Epistane (10-20mg). This product has shown extremely good anti estrogenic and gynecomastia reducing properties. However, it is a steroid, and there is a possibility that the gyno could return or worsen during post cycle therapy. Personally, I don't recommend any more than 20mg when your goal is to reduce gyno, but that is an argumentive point. I experienced growth at 30mg, but everyone responds differently. Just remember Epistane is an anabolic agent.
(1)
Raloxifene and Tamoxifen Treatment of Pubertal Gynecomastia
Lawrence and colleagues report their experience with the use of either raloxifene or tamoxifen, both antiestrogenic agents, in reducing breast size in adolescent boys with benign gynecomastia. The data presented are from a retrospective review of 37 patients: 12 received reassurance alone, 10 received raloxifene (60 mg once daily for 3 to 9 months), and 15 received tamoxifen (10 to 20 mg twice dialy for 3 to 9 months). Baseline studies including LH, FSH, testosterone, and estradiol levels were normal in all subjects and there were no significant differences among the groups with regard to age at initiation of treatment, Tanner stage, BMI or baseline hormone levels. Significant reductions in breast diameter were measured with both raloxifene (2.5cm, 66% reduction) and tamoxifen (2.1cm, 46% reduction). However, a 50% or greater reduction was seen more often in the raloxifene treated group (86% vs 41%). No side effects of the medications were reported.
Going to make this short and sweet.
Lots of guys on here wondering what the best protocol is for reducing, or getting rid of existing gyno. I've tried lots of things, and I'm going to outline a plan that is relatively safe, side effect free that got rid of my gyno, that I had for many years from puberty and PH.
I had REAL gyno. Lumps, tissue, pain, ugliness, puffiness. It was a mess.
The plan
Backup Plan: Epistane
ED - Everyday
EOD - Every other day
-
Week 1: 60mg Raloxifene ED + 50mg ATD ED
Week 2: 60mg Raloxifene ED + 25mg ATD ED
Week 3: 60mg Raloxifene ED + 25mg ATD ED
Week 4: 60mg Raloxifene ED + 25mg ATD EOD
Week 5: 60mg Raloxifene ED + 25mg ATD EOD
Week 6: 60mg Raloxifene ED + 25mg ATD EOD
Week 7: 60mg Raloxifene ED
Week 8: 60mg Raloxifene ED
Week 9: 30mg Raloxifene ED
Week 10: 30mg Raloxifene ED
-
Raloxifene
Studies have shown that Raloxifene has a better success rate of reducing the size of gynecomastia in men than Nolvadex(1). It is also less hepatoxic (harmful to the liver) than Nolvadex. 60mg is a standard dosage, which is tapered down to a half dose of 30mg for the last 2 weeks of the cycle in order to avoid rebound. Ralox also takes about 3 weeks to start working, therefore the full 10 weeks is nessecary.
ATD
At 25mg, ATD inhibits conversion of testosterone to estrogen without eliminating estrogen completely. The reason we keep this dosage low is to avoid side effects related to low estrogen, such as sore joints, lethargy and low libido. With an extreme tapering down of every other day dosing and Raloxifene to boot, there will be little to no rebound with this protocol.
I have seen extremely good results with low dosed Epistane (10-20mg). This product has shown extremely good anti estrogenic and gynecomastia reducing properties. However, it is a steroid, and there is a possibility that the gyno could return or worsen during post cycle therapy. Personally, I don't recommend any more than 20mg when your goal is to reduce gyno, but that is an argumentive point. I experienced growth at 30mg, but everyone responds differently. Just remember Epistane is an anabolic agent.
(1)
Raloxifene and Tamoxifen Treatment of Pubertal Gynecomastia
Lawrence and colleagues report their experience with the use of either raloxifene or tamoxifen, both antiestrogenic agents, in reducing breast size in adolescent boys with benign gynecomastia. The data presented are from a retrospective review of 37 patients: 12 received reassurance alone, 10 received raloxifene (60 mg once daily for 3 to 9 months), and 15 received tamoxifen (10 to 20 mg twice dialy for 3 to 9 months). Baseline studies including LH, FSH, testosterone, and estradiol levels were normal in all subjects and there were no significant differences among the groups with regard to age at initiation of treatment, Tanner stage, BMI or baseline hormone levels. Significant reductions in breast diameter were measured with both raloxifene (2.5cm, 66% reduction) and tamoxifen (2.1cm, 46% reduction). However, a 50% or greater reduction was seen more often in the raloxifene treated group (86% vs 41%). No side effects of the medications were reported.